Chemkart India Ltd

Chemkart India Ltd

₹ 238 -2.32%
01 Aug - close price
About

Incorporated in 2020, Chemkart India Limited, based in Mumbai, is a B2B nutraceutical ingredient distributor and processor.[1]

Key Points

Business Segment[1]
a) Trading Business:(97% of H1FY25 revenue)[2]
The company sources a wide range of nutraceutical ingredients—such as amino acids, vitamins, herbal extracts, and proteins—mainly through imports, and supplies them to B2B clients for manufacturing finished supplements.

  • Market Cap 287 Cr.
  • Current Price 238
  • High / Low 262 / 230
  • Stock P/E 20.6
  • Book Value
  • Dividend Yield 0.00 %
  • ROCE 62.0 %
  • ROE 64.0 %
  • Face Value 10.0

Pros

Cons

  • Working capital days have increased from 37.7 days to 64.8 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
87 131 132
80 120 112
Operating Profit 7 11 20
OPM % 8% 9% 15%
0 0 1
Interest 0 1 1
Depreciation 0 0 0
Profit before tax 7 11 19
Tax % 26% 28% 28%
5 8 14
EPS in Rs 40.46 58.73 102.73
Dividend Payout % 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 0%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 75%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 64%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
Equity Capital 1 1 1
Reserves 5 13 27
2 11 12
17 15 13
Total Liabilities 26 40 54
1 6 5
CWIP 0 0 0
Investments 0 0 0
25 35 49
Total Assets 26 40 54

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
-0 5 1
-1 -5 -0
1 1 -1
Net Cash Flow -0 0 -0

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2022 Mar 2023 Mar 2024
Debtor Days 81 62 88
Inventory Days 10 25 27
Days Payable 65 37 34
Cash Conversion Cycle 25 50 81
Working Capital Days 23 25 65
ROCE % 67% 62%

Shareholding Pattern

Numbers in percentages

8 Recently
Jul 2025
73.31%
1.77%
9.14%
15.78%
No. of Shareholders 1,190

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents